STOCK TITAN

ResMed (RMD) investor Michael Farrell plans 4,991-share stock sale after option exercise

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ResMed shareholder Michael Farrell lists a proposed sale of 4,991 shares of common stock, to be sold for cash on 08/07/2026 through Fidelity Brokerage Services LLC on the NYSE, in connection with a stock option exercise.

The disclosure also lists prior sales of 4,991 shares of common stock on each of 05/07/2026, 06/08/2026, and 07/07/2026, with aggregate sale prices of $1,037,232.61, $968,064.34, and $1,090,770.57, respectively.

Positive

  • None.

Negative

  • None.
Shares to be sold 4,991 shares Common stock listed as securities to be sold on 08/07/2026
Planned sale date 08/07/2026 Date for sale of 4,991 shares of common stock
Prior sale 1 amount $1,037,232.61 Aggregate amount for 4,991 shares sold on 05/07/2026
Prior sale 2 amount $968,064.34 Aggregate amount for 4,991 shares sold on 06/08/2026
Prior sale 3 amount $1,090,770.57 Aggregate amount for 4,991 shares sold on 07/07/2026
Shares sold past 3 months 14,973 shares 4,991 shares sold on each of three dates in May, June, and July 2026
Stock Option Exercise financial
"Common | 08/07/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Securities To Be Sold financial
"144: Securities To Be Sold Common | 08/07/2026"
Securities Sold During The Past 3 Months financial
"144: Securities Sold During The Past 3 Months Michael Farrell"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does ResMed (RMD) shareholder Michael Farrell plan to sell under this Form 144?

Michael Farrell plans to sell 4,991 shares of ResMed common stock for cash on 08/07/2026. The shares are associated with a stock option exercise and are to be sold through Fidelity Brokerage Services LLC on the NYSE.

On what date are the new ResMed (RMD) shares expected to be sold?

The planned sale date for the 4,991 shares of ResMed common stock is 08/07/2026. The transaction is tied to a stock option exercise and is designated as a cash sale on the NYSE via Fidelity Brokerage Services LLC.

Which broker is handling the proposed ResMed (RMD) share sale for Michael Farrell?

The proposed sale of 4,991 ResMed shares is listed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. The shares are to be sold for cash on the NYSE in connection with a stock option exercise dated 08/07/2026.

What prior ResMed (RMD) stock sales did Michael Farrell report in the last three months?

Michael Farrell reported selling 4,991 shares of ResMed common stock on 05/07/2026, 06/08/2026, and 07/07/2026, for aggregate amounts of $1,037,232.61, $968,064.34, and $1,090,770.57, respectively, over the past three months.

How many ResMed (RMD) shares has Michael Farrell sold recently in total according to this Form 144?

Over the past three months, Michael Farrell has sold 4,991 shares on each of three dates, totaling 14,973 shares. The aggregate sale proceeds listed are $1,037,232.61, $968,064.34, and $1,090,770.57 for those respective transactions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature